Phillip Chan Insider Trades & Stock Holdings

Chief Executive Officer · Cytosorbents Corporation · Latest filing Jun 15, 2026

Phillip Chan, Chief Executive Officer at Cytosorbents Corporation has 4 Form 4 trades on file since Jun 12, 2026. Open-market activity: 4 purchases ($209.80K) and 0 sales ($0), net +$209.80K. Latest filing: acquired 10.33K shares of $CTSO on Jun 15, 2026 at $0.43.

Trades on file

4

Open-market bought

$209.80K

Open-market sold

$0

Net open-market

+$209.80K

Latest filing

Jun 15, 2026

All insider trades by Phillip Chan

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 15, 2026	$CTSO	Buy (Open-market buy)	10.33K	$0.43	$4.44K			-4.4%	-10.0%		Chief Executive Officer		—
Jun 15, 2026	$CTSO	Buy (Open-market buy)	10.33K	$0.43	$4.44K			-4.4%	-10.0%		Chief Executive Officer		Read
Jun 12, 2026	$CTSO	Buy (Open-market buy)	251.14K	$0.40	$100.45K			+3.2%	-5.0%		Chief Executive Officer		Read
Jun 12, 2026	$CTSO	Buy (Open-market buy)	251.14K	$0.40	$100.45K			+3.2%	-5.0%		Chief Executive Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Phillip Chan traded

• $CTSO

Frequently asked questions

Has Phillip Chan been buying or selling stock?

Phillip Chan has 4 open-market purchases and 0 open-market sales on file, net +$209.80K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Phillip Chan's latest insider trade?

acquired 10.33K shares of $CTSO on Jun 15, 2026 at $0.43.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.